Children

What’s Best for Eczema (Atopic Dermatitis): Coconut Oil vs. Mineral Oil vs. Vaseline

  • by

Natural topical remedies for eczema, including licorice root gel, St. John’s Wort cream, and emollients such as coconut oil, mineral oil, and petroleum jelly, are put to the test. Despite the availability of drugs with proven efficacy for eczema, like topical steroids, many patients seek… Read More »What’s Best for Eczema (Atopic Dermatitis): Coconut Oil vs. Mineral Oil vs. Vaseline

Roche’s Evrysdi (risdiplam) Receives Health Canada’s Approval for Spinal Muscular Atrophy in Adults and Children

  • by

Shots: The approval is based on two studies i.e. FIREFISH & SUNFISH. The FIREFISH study involves assessing Evrysdi in infants aged 2-7mos. with symptomatic Type 1 SMA, and the SUNFISH study assesses Evrysdi in children & young adults aged 2-25yrs. with Type 2 or 3… Read More »Roche’s Evrysdi (risdiplam) Receives Health Canada’s Approval for Spinal Muscular Atrophy in Adults and Children

J&J Vision Collaborates with Menicon to Offer Contact Lenses for Managing the Progression of Myopia in Children

  • by

Shots: Menicon to develop and manufacture contact lenses to help manage the progression of myopia in children. J&J Vision will focus on expanding the availability of these lenses across the globe The collaboration will combine the expertise of both the companies and allow J&J to… Read More »J&J Vision Collaborates with Menicon to Offer Contact Lenses for Managing the Progression of Myopia in Children

BioMarin Report Results of Vosoritide in P-III OLE Study for the Treatment of Children with Achondroplasia at ENDO 2021

  • by

Shots: The ongoing P-III OLE study involves assessing Vosoritide (15 mcg/kg) vs PBO in 119 children with achondroplasia. The CHMP opinion is expected in Europe in June 2021 The results demonstrated increased AGV, baseline mean AGV of 4.28 cm/year, sustained restoration of a major portion… Read More »BioMarin Report Results of Vosoritide in P-III OLE Study for the Treatment of Children with Achondroplasia at ENDO 2021

Sanofi’s Dupixent (dupilumab) Receives Health Canada Approval as the First Biologic to Treat Atopic Dermatitis in Children

  • by

Shots: Health Canada has approved Dupixent for the treatment of mod. to sev. AD in children aged 6 to 11yrs. whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable The approval marks the fifth indication for Dupixent… Read More »Sanofi’s Dupixent (dupilumab) Receives Health Canada Approval as the First Biologic to Treat Atopic Dermatitis in Children

Arsenic in Infant Rice Cereal

  • by

When it comes to rice and rice-based products, pediatric nutrition authorities have recommended that arsenic intake should be as low as possible. “The US Food and Drug Administration (FDA) has been monitoring the arsenic content in foods” for decades, yet despite the “well-established science describing… Read More »Arsenic in Infant Rice Cereal

Abbott’s FreeStyle Libre 2 Receives Health Canada’s Approval for Adults and Children with Diabetes

  • by

Shots: Abbott’s next-generation, sensor-based glucose monitoring technology, FreeStyle Libre 2, received Health Canada’s approval for adults & children with diabetes The system continuously measures glucose data every minute with customizable, optional real-time alarms to alert users when their glucose is high/low without scanning The technology… Read More »Abbott’s FreeStyle Libre 2 Receives Health Canada’s Approval for Adults and Children with Diabetes

Why Was Chicken the Primary Source of Arsenic Exposure in Children?

  • by

What was the National Chicken Council’s response to public health authorities calling for the industry to stop feeding arsenic-based drugs to poultry? “Dietary practices influence our exposure to pesticides, toxic heavy metals, persistent organic pollutants, and industrial pollutants….A diet high in fish and other animal products,… Read More »Why Was Chicken the Primary Source of Arsenic Exposure in Children?

Biomarin Reports the US FDA’s Acceptance of Vosoritide’s NDA to Treat Children with Achondroplasia

  • by

Shots: The acceptance marks the first marketing application accepted for achondroplasia in the US with an anticipated PDUFA date as of Aug 20, 2021. The US FDA is not planning to hold an advisory committee meeting to discuss the application Additionally, the company is expecting… Read More »Biomarin Reports the US FDA’s Acceptance of Vosoritide’s NDA to Treat Children with Achondroplasia

Adult Exposure to Lead

  • by

“Children in approximately 4 million households in the United States are being exposed to high levels of lead.” As I discuss in my video The Effects of Low-Level Lead Exposure in Adults, “Despite the dramatic decline in children’s blood-lead concentrations over the decades, lead toxicity… Read More »Adult Exposure to Lead

BioMarin Reports NDA Submission to the US FDA for Vosoritide to Treat Children with Achondroplasia

  • by

Shots: BioMarin has submitted an NDA to the US FDA for vosoritide to treat children with achondroplasia The company also reported that EMA has begun validation of MAA for the therapy on 13 Aug, 2020 Vosoritide is an investigational, once-daily injection analog of C-type Natriuretic… Read More »BioMarin Reports NDA Submission to the US FDA for Vosoritide to Treat Children with Achondroplasia

Brief Examines What’s Known About Children and Coronavirus Transmission as Schools Prepare for Fall

  • by

With schools nationwide preparing for fall and the federal government encouraging in-person classes, key concerns for school officials, teachers and parents include the risks that coronavirus poses to children and their role in transmission of the disease. A new KFF brief examines the latest available data… Read More »Brief Examines What’s Known About Children and Coronavirus Transmission as Schools Prepare for Fall

What Do We Know About Children and Coronavirus Transmission?

  • by

As schools prepare for Fall, this brief examines what’s known about children and COVID-19, including the risk the virus poses to children and the risk of children becoming infected and transmitting to others, and the experiences of other countries that reopened classrooms.

BioMarin Reports the Submission of MAA to EMA for Vosoritide to Treat Children with Achondroplasia

  • by

Shots: The MAA is based on P-III study assessing the efficacy and safety of vosoritide, further supported by the long-term safety and efficacy from the ongoing P-II and P-III extension studies and extensive natural history data Following the completion of EMA’s validation, BioMarin expects the… Read More »BioMarin Reports the Submission of MAA to EMA for Vosoritide to Treat Children with Achondroplasia

By Nearly a 2-1 Margin, Parents Prefer to Wait to Open Schools to Minimize COVID Risk, with Parents of Color Especially Worried Either Way

  • by

Most Say Things Will Get Worse Before They Get Better, and Just Over Half Now Say Their Mental Health is Worse Because of Coronavirus Worry and Stress As state and local officials prepare for the new school year amid the COVID-19 pandemic, parents with children… Read More »By Nearly a 2-1 Margin, Parents Prefer to Wait to Open Schools to Minimize COVID Risk, with Parents of Color Especially Worried Either Way

KFF Health Tracking Poll – July 2020

  • by

This poll examines the public’s views on reopening society during the coronavirus pandemic, as well as parents’ worries when it comes to their children returning or not returning to school, the mental health and economic effects, and priorities for possible congressional action.